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Objective: The purpose of this feasibility study was to assess the safety and performance of the Stentys self-expanding coronary stent in patients 
with an acute myocardial infarction.
Background: Self-expanding stents, by following the contours of the vessel wall without the need for strong post dilatation, might show better 
apposition and diminish the risk for underexpansion of the stent, which is a predictor of early stent thrombosis. Early follow-up of the patients 
through IVUS/OCT is important to assess vessel lumen growth following thrombus and spasm resolution, to examine protrusion of material through 
the stent struts, stent malapposition and presence of in-hospital stent thrombosis.
Methods: A prospective, multi-center, non-randomized study enrolled 25 STEMI patients undergoing PCI of a de-novo lesion. Angiographic and 
IVUS/OCT evaluation were performed post-procedure, after 3 days and at 6 months. Endpoints were MACE, stent expansion and apposition after 3 
days and 6 months, vessel lumen area, stent area and device success.
Results: Technical success was achieved in all 25 patients (100%). IVUS results showed a 2% increase of the Mean Reference Area proximally and 
23% distally. The Minimal Lumen Area and Mean Stent Area increased 20% at 3 days (p<0.001). There was no MACE nor stent thrombosis until 30 
days follow-up.
Conclusions: The Stentys stent is safe and effective in the treatment of ACS The APPOSITION I study showed that vasodilation distal to the 
thrombotic site is significant. It needs to be further studied how apposition to the vessel wall exerts a clinical benefit.
